Donoghue Forlines LLC Abiomed Inc Transaction History

Donoghue Forlines LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$242.49 - $301.46 $377,314 - $469,071	-1,556 Reduced 61.87%	959 $236,000
Q2 2022 Aug 08, 2022	SELL	$224.73 - $338.64 $64,722 - $97,528	-288 Reduced 10.27%	2,515 $622,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $226,236 - $298,892	816 Added 41.07%	2,803 $928,000
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $133,479 - $164,879	444 Added 28.78%	1,987 $714,000
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $478,623 - $580,476	1,543 New	1,543 $502,000
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $705,078 - $875,750	-2,466 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$251.88 - $324.2 $644,057 - $828,979	-2,557 Reduced 50.91%	2,466 $799,000
Q3 2020 Nov 16, 2020	BUY	$255.22 - $317.0 $1.28 Million - $1.59 Million	5,023 New	5,023 $1.39 Million
Q3 2018 Oct 26, 2018	SELL	$354.53 - $449.75 $1.91 Million - $2.42 Million	-5,388 Closed	0 $0
Q2 2018 Jul 26, 2018	BUY	$278.07 - $446.21 $1.5 Million - $2.4 Million	5,388 New	5,388 $2.2 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.